Amlodipine Besylate/Azilsartan/Hydrochlorothiazide

苯磺酸氨氯地平/阿齐沙坦/氢氯噻嗪

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAmlodipine Besylate/Azilsartan/Hydrochlorothiazide
Drug Alias Name阿齐沙坦/氢氯噻嗪/苯磺酸氨氯地平Azilsartan/amlodipine/hydrochlorothiazide苯磺酸氨氯地平/氢氯噻嗪/阿齐沙坦Azilsartan/hydrochlorothiazide/amlodipineAmlodipine/hydrochlorothiazide/azilsartan +[10] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockersThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsYes HydrochlorothiazideAzilsartanAmlodipine Besylate
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsEssential HypertensionHypertension

Other Information

ATC CodeN/A
Related LinksN/A